BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 6980949)

  • 1. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
    Fisher RI; Bostick-Bruton F
    J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
    Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
    Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM; Herzig GP
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin-producing suppressor cells in Hodgkin's disease.
    Goodwin JS; Messner RP; Bankhurst AD; Peake GT; Saiki JH; Williams RC
    N Engl J Med; 1977 Nov; 297(18):963-8. PubMed ID: 409950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients.
    Haim N; Meidav A; Samuelly B; Segal R; Mekori T; Robinson E
    J Biol Response Mod; 1984; 3(2):219-25. PubMed ID: 6233397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody response in cultures of lymphocytes from patients with Hodgkin's lymphoma: role of monocytes].
    Villa ML; Colleoni M; Valenti F; Tondini C; Clerici E
    Boll Ist Sieroter Milan; 1987; 66(3):214-21. PubMed ID: 3325076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
    Alberola V; González-Molina A; Trenor A; San Martín B; Lluch A; Palau F; Marín J; García-Conde FJ
    Allergol Immunopathol (Madr); 1985; 13(3):213-9. PubMed ID: 2931010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
    Fisher RI; Bates SE; Bostick-Bruton F; Tuteja N; Diehl V
    J Immunol; 1984 May; 132(5):2672-7. PubMed ID: 6609204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
    Bockman RS
    J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
    Sibbitt WL; Bankhurst AD; Williams RC
    J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
    Holdstock G; Chastenay BF; Krawitt EL
    Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.
    Fisher RI; Bostick-Bruton F; Sauder DN; Scala G; Diehl V
    J Immunol; 1983 Jun; 130(6):2666-70. PubMed ID: 6222113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human lymphocyte responses in chronic renal failure mediated by adherent cells: analysis in serum-free media.
    Kleiman KS; Zoschke DC
    J Lab Clin Med; 1985 Sep; 106(3):262-8. PubMed ID: 3928781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease.
    Holm G; Björkholm M; Mellstedt H; Nilsson P
    J Clin Lab Immunol; 1982 Jan; 7(1):51-4. PubMed ID: 6461767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte function in Hodgkin's disease.
    Holm G; Björkholm M; Johansson B; Mellstedt H; Lindemalm C
    Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent T gamma cell functions in antigen-induced blastogenesis: facilitory interactions with Tnon gamma cells and participation in monocyte- and prostaglandin-mediated suppression.
    Kleinhenz ME; Ellner JJ
    J Lab Clin Med; 1983 Nov; 102(5):751-61. PubMed ID: 6226756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J; Levanon M; Davidsohn J; Ramot B
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
    Shiftan TA; Caviles AP; Mendelsohn J
    Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
    Koster FT; Williams JC; Goodwin JS
    J Immunol; 1985 Aug; 135(2):1067-72. PubMed ID: 2409135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.